Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$53.22 - $123.09 $25.6 Million - $59.1 Million
-480,397 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$101.89 - $150.09 $44,016 - $64,838
432 Added 0.09%
480,397 $55.9 Million
Q4 2021

Feb 11, 2022

BUY
$118.18 - $153.21 $56.7 Million - $73.5 Million
479,965 New
479,965 $72.2 Million
Q1 2021

May 11, 2021

SELL
$81.28 - $104.34 $11.3 Million - $14.5 Million
-138,971 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$86.4 - $121.75 $24.9 Million - $35 Million
-287,809 Reduced 67.44%
138,971 $13.3 Million
Q3 2020

Nov 12, 2020

BUY
$95.43 - $116.09 $2.29 Million - $2.79 Million
24,012 Added 5.96%
426,780 $48.4 Million
Q2 2020

Aug 14, 2020

BUY
$60.05 - $98.92 $24.2 Million - $39.8 Million
402,768 New
402,768 $39.8 Million
Q1 2020

May 14, 2020

SELL
$47.37 - $90.04 $10.3 Million - $19.5 Million
-217,061 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$53.13 - $71.19 $31.6 Million - $42.4 Million
-595,564 Reduced 73.29%
217,061 $12.9 Million
Q3 2019

Nov 14, 2019

SELL
$57.11 - $73.3 $43.9 Million - $56.4 Million
-768,995 Reduced 48.62%
812,625 $47.9 Million
Q2 2019

Aug 14, 2019

SELL
$54.41 - $71.7 $9.7 Million - $12.8 Million
-178,338 Reduced 10.13%
1,581,620 $102 Million
Q1 2019

May 15, 2019

SELL
$32.25 - $73.56 $1.65 Million - $3.75 Million
-51,008 Reduced 2.82%
1,759,958 $112 Million
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $10.4 Million - $14.8 Million
365,261 Added 25.27%
1,810,966 $68.8 Million
Q3 2018

Nov 14, 2018

BUY
$21.39 - $51.17 $20.4 Million - $48.7 Million
952,506 Added 193.13%
1,445,705 $61.9 Million
Q2 2018

Aug 14, 2018

BUY
$4.9 - $23.64 $2.42 Million - $11.7 Million
493,199 New
493,199 $10.9 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.31B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.